Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.British journal of pharmacology · 2026-06-30Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-01Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-13A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.ClinicalTrials.gov · 2026-05-11Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09Psilocybin effects on brain functional connectivity: a systematic review of fMRI studiesDiscover Mental Health · 2026-03-18A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-03-12Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-08Preclinical evaluation of psilocybin as an anti-inflammatory agentNeuroscience Applied · 2025-12-31Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortexbioRxiv · 2025-12-25Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challengesMycological Progress · 2025-12-07Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyUnknown journal · 2025-11-30Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute PsilocybinEuropean Journal of Neuroscience · 2025-11-30CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-10-31Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applicationsCaderno Pedagógico · 2025-10-30Psilocybin use in bipolar disorder: A comprehensive review.Unknown journal · 2025-10-30Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Unknown journal · 2025-10-22Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-14Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis.Unknown journal · 2025-08-27Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.Unknown journal · 2025-08-22Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives.Unknown journal · 2025-06-30Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case reportThe poison. · 2025-06-29The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping ReviewPreprints.org · 2025-06-18Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stressTranslational Psychiatry · 2025-06-13The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-04-30Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de ArgentinaBoletín de la Sociedad Argentina de Botánica · 2025-03-31Age- and estrous-dependent effects of psilocybin in ratsbioRxiv · 2025-01-13Mushroom poisoning: An updated review.Unknown journal · 2025-01-01Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in Psychiatry and Psychotherapy · 2024-12-31The safety of psilocybin-assisted psychotherapy: A systematic review.Unknown journal · 2024-12-12The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.Unknown journal · 2024-12-09Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.Unknown journal · 2024-12-03Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) TrialCanadian Journal of Pain · 2024-11-07Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius haematocephalusBrazilian Journal of Science · 2024-10-31Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.Unknown journal · 2024-08-20Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.Unknown journal · 2024-08-17Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depressionPsychopharmacology · 2024-07-03Licit use of illicit drugs for treating depression: the pill and the process.Unknown journal · 2024-06-16Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelicsbioRxiv · 2024-06-15The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin.Unknown journal · 2024-06-03WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinAmerican Journal of Therapeutics · 2024-02-29Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2023-12-31Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recoveryTherapeutic Advances in Psychopharmacology · 2023-12-31Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and PhenomenologybioRxiv · 2023-10-06Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-19Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorderJournal of Psychiatric Research · 2023-03-27Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health.BMC psychiatry · 2023-03-13Acute psilocybin enhances cognitive flexibility in ratsbioRxiv · 2023-01-08Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controlsNeuroscience Applied · 2022-12-31Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteersmedRxiv · 2022-10-31Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.Journal of psychopharmacology (Oxford, England) · 2022-09-30P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-08-31Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.Unknown journal · 2022-07-10Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.Unknown journal · 2022-05-22Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.Unknown journal · 2022-02-10Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in miceNeuroscience Applied · 2021-12-31P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?Revista Portuguesa de Psiquiatria e Saúde Mental · 2021-09-07Treating addiction with psychedelics - are we waking up?Unknown journal · 2021-08-12Effects of psilocybin-assisted therapy on treatment-resistant depressionUnknown journal · 2021-08-12Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.Unknown journal · 2021-07-26O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depressionBrazilian Journal of Health Review · 2021-04-18Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?European Psychiatry · 2021-03-31Psychedelics as a Treatment for Alzheimer's Disease Dementia.Unknown journal · 2020-08-20Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushroomsJournal of Pharmaceutical and Biomedical Analysis · 2020-07-20Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-06-30Self-reported negative outcomes of psilocybin users: A quantitative textual analysisPLoS ONE · 2020-02-20An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-07Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30Relationship Of Magic Mushroom Literation As A Drug With Abuse It's Use As A HallucinationInternational Journal on Advanced Science Education and Religion · 2019-03-27Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance.Science & Justice · 2018-08-20Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical Pharmacokinetics · 2017-11-30DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.Journal of Pharmaceutical and Biomedical Analysis · 2016-03-22The hallucinogenic world of tryptamines: an updated review.Unknown journal · 2015-04-15Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and PsilocinJournal of Analytical & Bioanalytical Techniques · 2014-12-31Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-03-31Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Unknown journal · 2002-12-31Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro StudiesInternational journal of medicinal mushrooms · 1999-12-31Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.Unknown journal · 1999-05-31Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.Unknown journal · 1997-04-30Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.Unknown journal · 1965-08-31[THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].Unknown journal · 1964-12-31LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.Unknown journal · 1963-09-30[Psilocybin: prospects of its use in clinical psychiatry].Unknown journal · 1963-01-31